Incretin
ObesityTreatment
Which type are you?
Wegovy
Active ingredient
Semaglutide
Dosage interval
Once a week
Mechanism of action
GLP-1 receptor
Maximumcapacity
2.4mg
Weight loss
effect
14.9%（68weeks）
Merit
Reliable with abundant
long-term data
FDA Approval Date
June 2021
Wegovy is officially approved in Japan and, although not covered by insurance, can be legally prescribed under a doctor's supervision.
Zepbound
Active ingredient
Tirzepatide
Dosage interval
Once a week
Mechanism of action
GLP-1/GIP receptor
Maximumcapacity
15.0mg
Weight loss
effect
22.7%（72weeks）
Merit
Fewer injections
FDA Approval Date
November 2023
It has been approved for manufacturing and sales in Japan as an obesity treatment . The active ingredient is the same as that of the diabetes treatment drug "Manjaro."
.png)
Which drug is best for the patient? We will consider the patient's condition and wishes.
Based on your examination, your doctor will recommend the most appropriate treatment.
If you require a prescription medication, please consult your doctor.
What is Wegovy ?
GLP-1 injection "Ugobi" gently stimulates the "appetite switch" deep within the body, naturally suppressing overeating. Before you know it, you will be snacking less and feeling satisfied with smaller portions. This medicine allows you to experience a gradual change in your habits, rather than a painful endurance. It is gentle on both the mind and body, and supports a natural diet and improvement of your constitution.
.png)
.png)
What is Zepbound ?
This drug stimulates not only GLP-1 (glucagon-like peptide) receptors but also GIP (glucose-dependent insulinotropic polypeptide) receptors. GLP-1 suppresses appetite, while GIP promotes insulin secretion to control blood sugar levels.These actions can lead to healthy weight management.
Wegovy may be a new option for weight management!
_edited.png)
_edited.png)
_edited.png)
Pricing Plans
wegovy
1month（1pieces）
0.5mg
??,???
JPY
（tax included）
1.0mg
??,???
JPY
（tax included）
1.7mg
??,???
JPY
（tax included）
2.4mg
??,???
JPY
（tax included）
wegovy
2month（2pieces）
0.5mg
??,???
JPY
（tax included）
1.0mg
??,???
JPY
（tax included）
1.7mg
??,???
JPY
（tax included）
2.4mg
??,???
JPY
（tax included）
wegovy
3month（3pieces）
0.5mg
??,???
JPY
（tax included）
1.0mg
??,???
JPY
（tax included）
1.7mg
??,???
JPY
（tax included）
2.4mg
??,???
JPY
（tax included）
First visit
Zepbound
4pieces（1month）
24,200
JPY
2.5mg 4pieces
（tax included）
Zepbound
8pieces（2month）
2.5mg 4pieces
5.0mg 4pieces
64,900
JPY
（tax included）
Zepbound
12pieces（3month）
2.5mg 4pieces
5.0mg 8pieces
146,300
JPY
（tax included）
Zepbound
16pieces（4month）
2.5mg 4pieces
5.0mg 12pieces
187,000
JPY
（tax included）
Returning patients or those transferring
Zepbound
4pieces（1month）
2.5mg
24,200
JPY
（tax included）
5.0mg
40,700
JPY
（tax included）
7.5mg
Scheduled to arrive sequentially
10mg
Scheduled to arrive sequentially
12.5mg
Scheduled to arrive sequentially
15mg
Scheduled to arrive sequentially
Online medical appointment fee
Face-to-face appointment fee
Shipping fee (nationwide flat rate)
???
JPY
（tax included）
???
JPY
（tax included）
???
JPY
（tax included）
Credit card payment accepted
Credit card payments are
We only accept Visa, MasterCard, JCB, American Express and Diners .
If you would like to pay by a method other than credit card, please consult with your doctor after your examination.
Bank transfer is also available. Please contact us for details.
This medical treatment is not covered by insurance. (The consultation fee is included in the price of the drug.)
Please note that in addition to the cost of medication (which is included in the medical fee), you will be responsible for reservation fees and shipping costs.
In case of cancellation, the booking fee will be refunded.
If you are unable to continue for medical reasons, please consult with your doctor.
We will refund the remaining service fees.
A clinic with a proven track record in treating diabetes and obesity
HDC Atlas Clinic
A diabetes clinic offering cutting-edge medical care
Cases requiring insulin therapy using new drugs
By reducing the number of patients, more patients will come to the hospital from all over the country.
Launching online medical consultations for obesity treatment
To date, we have treated over 1600 patients.
To spread correct knowledge about diabetes and obesity treatment
He has published many books
Director of HDC Atlas Clinic
Yoshihiko Suzuki
Doctor of Medicine MD, Ph.D.
Graduated from Keio University School of Medicine (Class of 62)
13 years (2005 to March 2018)
Former visiting professor at Nippon Medical School, member of the European Association for the Study of Diabetes, specialist at the Japan Diabetes Society
2016 Edition: Ranking of Best Doctors for the People
2018 Edition: Ranking of Best Doctors for the People
Ranking of Best Doctors for the Nation 2021~2023
He has published numerous papers.
20 articles in the Journal of the Japan Diabetes Society
15 articles in the American Diabetes Association Journal
5 articles in the European Journal of Diabetes
13 articles in the International Journal of Diabetes
Others include NEJM, Lancet , Metabolism, Neurology, February Letter, etc.
Side effects and risks
Nausea, vomiting, loss of appetite, stomach upset, fatigue
Main Side Effects
Acute pancreatitis, intestinal obstruction, acute kidney injury
Serious Side Effects
Zepbound also carries the risk of rare, but more serious, side effects. For example, the risk of pancreatitis. If you experience severe upper abdominal pain or nausea, consult your doctor immediately.
Previous animal studies have shown an increased risk of medullary thyroid cancer and multiple endocrine neoplasia (MEN) type 2. Although this risk has not yet been fully elucidated in humans, Zepbound is contraindicated for use by people who have had these diseases in the past or have family members who have had these diseases. If you experience symptoms of a thyroid tumor (e.g., a mass in the neck, difficulty swallowing, difficulty breathing, persistent hoarseness), consult your doctor.
The use of Zepbound has also been associated with acute kidney injury, which may result from dehydration due to gastrointestinal side effects and may include nausea, vomiting, and diarrhea. Hemodialysis may also be required. Some of these events have been reported in patients with no known underlying renal disease. The majority of reported events occurred in patients who experienced nausea, vomiting, diarrhea, or dehydration.
Furthermore, it has been pointed out that rapid weight loss may affect internal organs and hormone balance. Therefore, regular health checks are essential when using Zepp Bound.
Atlas Building 1F, 5-3 Ichibancho, Chiyoda-ku, Tokyo
Telephone reception hours: Monday to Saturday Morning | 10:00-13:00 Afternoon | 14:00-16:30
(Saturdays only until 13:30)
access
Tokyo Metro Hanzomon Line: 2 minutes walk from Hanzomon Station, Exit 5
Tokyo Metro Yurakucho Line: 7 minutes walk from Kojimachi Station, Exit 3